Publications

Extremely Differentiated T Cell Subsets Contribute to Tissue Deterioration During Aging

Soto-Heredero G, Gómez de Las Heras MM, Escrig-Larena JI, Mittelbrunn M.

Annu Rev Immunol. 2023 Apr;

26;41:181-205.
DOI: 10.1146/annurev-immunol-101721-064501.
PMID: 37126417

There is a dramatic remodeling of the T cell compartment during aging. The most notorious changes are the reduction of the naive T cell pool and the accumulation of memory-like T cells. Memory-like T cells in older people acquire a phenotype of terminally differentiated cells, lose the expression of costimulatory molecules, and acquire properties of […]

Immuno(T)herapy for age-related diseases

Gabandé-Rodríguez E, Pfeiffer M, Mittelbrunn M.

EMBO Mol Med. 2023 Jan;

15(1):e16301.
DOI: 10.15252/emmm.202216301.
PMID: 36373340

During the last decade, the stimulation of T-cell function by the blockage of immunosuppressive checkpoints has experienced an outstanding impact in the treatment of cancer. Development of the chimeric antigen receptor T-cell technology has also emerged as a powerful alternative for patients suffering from oncological processes, especially those affected by hematological neoplasms. Recent evidence suggest […]

Nicotinamide adenine dinucleotide metabolism in the immuneresponse, autoimmunity and inflammageing

Navarro MN, Gómez de Las Heras MM, Mittelbrunn M.

Br J Pharmacol. 2022 May;

179(9):1839-1856.
doi: 10.1111/bph.15477.
PMID: 33817782 .

Metabolism is dynamically regulated to accompany immune cell function, and altered immunometabolism can result in impaired immune responses. Concomitantly, the pharmacological manipulation of metabolic processes offers an opportunity for therapeutic intervention in inflammatory disorders. The nicotinamide adenine dinucleotide (NAD+ ) is a critical metabolic intermediate that serves as enzyme cofactor in redox reactions, and is […]